FFA
INMB icon

Farther Finance Advisors’s INmune Bio INMB Stock Holding History

Farther Finance Advisors’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$602 Buy
370
+318
+612% +$440 ﹤0.01% 5498
2026
Q1 		$64 Buy
+52
New +$74 ﹤0.01% 5553

Other funds holding INMB

CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

Farther Finance Advisors's INMB Position: Q2 2026 in Review

Farther Finance Advisors increased its INmune Bio (INMB) stake by 612% in Q2 2026, buying an estimated $440 and bringing the position to 370 shares worth $602. The position accounts for ﹤0.01% of the portfolio, ranked #5498.

Farther Finance Advisors first reported a position in INMB in Q1 2026 and has held it in 2 quarters since. 8 funds tracked by Wall St. Rank hold INMB as of Q2 2026.

  • Farther Finance Advisors held 370 shares of INmune Bio worth $602 as of Q2 2026.
  • Farther Finance Advisors bought 318 INmune Bio shares in Q2 2026, an estimated $440.
  • INmune Bio made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5498 holding.
  • Farther Finance Advisors first reported a position in INmune Bio in Q1 2026 and has held it in 2 quarters since.
  • 8 funds tracked by Wall St. Rank held INmune Bio as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.